2024-04-01 2025-03-31 false Capium Accounts Production 1.1 12506062 2024-04-01 2025-03-31 12506062 bus:AbridgedAccounts 2024-04-01 2025-03-31 12506062 bus:FRS102 2024-04-01 2025-03-31 12506062 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12506062 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12506062 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12506062 2024-04-01 2025-03-31 12506062 2025-03-31 12506062 bus:RegisteredOffice 2024-04-01 2025-03-31 12506062 core:WithinOneYear 2025-03-31 12506062 core:AfterOneYear 2025-03-31 12506062 1 2024-04-01 2025-03-31 12506062 bus:Director1 2024-04-01 2025-03-31 12506062 bus:Director1 2025-03-31 12506062 bus:Director1 2023-04-01 2024-03-31 12506062 2023-04-01 12506062 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 12506062 2023-04-01 2024-03-31 12506062 2024-03-31 12506062 core:WithinOneYear 2024-03-31 12506062 core:AfterOneYear 2024-03-31 12506062 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 12506062 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12506062 bus:OrdinaryShareClass1 2025-03-31 12506062 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12506062 bus:OrdinaryShareClass1 2024-03-31 12506062 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 12506062 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 12506062 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 12506062 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12506062 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12506062 core:Non-currentFinancialInstruments 2025-03-31 12506062 core:Non-currentFinancialInstruments 2024-03-31 12506062 core:ShareCapital 2025-03-31 12506062 core:ShareCapital 2024-03-31 12506062 core:RetainedEarningsAccumulatedLosses 2025-03-31 12506062 core:RetainedEarningsAccumulatedLosses 2024-03-31 12506062 dpl:Item1 2024-04-01 12506062 dpl:Item1 2025-03-31 12506062 dpl:Item1 2023-04-01 12506062 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12506062
England and Wales
ALPADOCTORS LIMITED
Abridged Accounts
Period of accounts Start date: 01 April 2024 End date: 31 March 2025

Alpadoctors Limited Contents Page For the year ended 31 March 2025
Statement of financial position | 1
Notes to the financial statements | 2

Alpadoctors Limited Statement of Financial Position As at 31 March 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Current assets |  |  |
Cash at bank and in hand |  | 536 |  | (5,213)
Creditors: amount falling due within one year |  | (25,673) |  | (26,274)
Net current assets |  | (25,137) |  | (31,487)
Total assets less current liabilities |  | (25,137) |  | (31,487)
Net assets |  | (25,137) |  | (31,487)
Capital and reserves |  |  |
Called up share capital | 3 | 3 |  | 3
Profit and loss account |  | (25,140) |  | (31,490)
Shareholders' funds |  | (25,137) |  | (31,487)
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 31 March 2026 and were signed by:
------------------------------- Mitesh Umedlal Parmar Director
1

Alpadoctors Limited Notes to the Abridged Financial Statements For the year ended 31 March 2025
General Information Alpadoctors Limited is a private company, limited by shares, registered in England and Wales, registration number 12506062, registration address 438 Streatham High Road, London, SW16 3PX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
3. | Share Capital
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
3 Class A shares of £1.00 each | 3 |  | 3
| 3 |  | 3
2